Overview
Financials
Revenue history (in m)
Filing timeliness
4 of 6 financial statements were filed late (the longest delay 158 days for 2021). All were audited by a statutory auditor.
- 202522/06/2026
- 202402/07/2025
- 202318/09/2024
- 202221/09/2023
- 202120/12/2022
- 202019/10/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Trademarks
Przedsiębiorstwo Farmaceutyczne Jelfa currently holds no active trademarks with the Polish Patent Office. 39 marks have expired or were not registered. The first mark was filed in 1989.
| Mark | Protected until | |
|---|---|---|
| Piabethos(word) | – | |
| TIMODOLUX(word) | – | |
| OftidorDuo(word) | – | |
| Mark without a word element(figurative) | – | |
| BITEFINA(word) | – |
Authorized Representatives
Manner of representation
Joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations of will and sign on behalf of the company.
Supervisory board
Ownership
| Owner |
|---|
Bausch+lomb Ops B.v. |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 1993-07-05.
36 1030 1508 0000 0008 1660 1002
38 1240 1301 1111 0000 2578 5922- 61 1030 1508 0000 0008 1660 1037
Debt
No entries in the National Debtors Register (KRZ).
Real estate
| Type | Amount |
|---|---|
Land (incl. perpetual usufruct) | $46,997$46,997 |
Buildings and premises | $9.4M$9,415,191 |
MSiG notices
| Publication date | Event | |
|---|---|---|
| Jan 14, 2021 | Commercial Companies Code notice | |
| Oct 28, 2020 | Bankruptcy notice | |
| Sep 29, 2020 | Commercial Companies Code notice | |
| Mar 28, 2013 | Transformation registered | |
| Mar 5, 2013 | Transformation registered |
Public aid
5 public aid cases recorded, with a total value of $455,787.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Dec 23, 2024 | Aid to cover additional costs related to an exceptionally significant increase in natural gas and electricity prices as a result of the war in Ukraine | –– | Prezes Zarządu Narodowego Funduszu Ochrony Środowiska i Gospodarki Wodnej | |
| Dec 18, 2023 | Aid to cover additional costs related to an exceptionally significant increase in natural gas and electricity prices as a result of the war in Ukraine | –– | Prezes Zarządu Narodowego Funduszu Ochrony Środowiska i Gospodarki Wodnej | |
| Jul 21, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | –– | Zarządca Rozliczeń S.A. |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | Waste generation | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| ICN Polfa RzeszówS.A. | $85,044,250.03 | icnpolfa.pl | ||
| Synoptis Pharmasp. z o.o. | $79,311,000.88 | synoptispharma.pl | ||
| PolfarmexS.A. | $73,543,379.32 | polfarmex.pl | ||
| BiotonS.A. | $71,777,247.61 | bioton.com | ||
| Celon PharmaS.A. | $51,765,221.75 | celonpharma.com | ||
| SUN-Farmsp. z o.o. | $51,063,341.52 | sunfarm.pl | ||
| Wrocławskie Zakłady Zielarskie HerbapolS.A. | $46,537,868.51 | herbapol.pl | ||
| US Pharmaciasp. z o.o. | $41,267,631.19 | uspharmacia.pl |
Change history
| Date | Event | |
|---|---|---|
| 2006-12-29 | Share capital increase (27,200,000.00 PLN → 27,316,160.00 PLN) | |
| 2001-12-04 | Entered in the register |
FAQ
Last updated: 2026-08-25